An interventional study of Glow Shakes Premium Collagen Meal Replacement Intervention in Weight Management, Obesity and Nutritional Adequacy, sponsored by The Collagen Co. - GLP-1 Users. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by The Collagen Co. - GLP-1 Users · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This is a single-group, open-label, decentralized clinical trial evaluating the effects of 12 weeks of once-daily consumption of Glow Shakes Premium Collagen Meal Replacement on nutritional adequacy, body composition, skin health, satiety, and overall wellness in 40 adults aged 18-55 years who are currently using a GLP-1 receptor agonist or dual-incretin medication for weight management. All study activities are conducted remotely; participants complete questionnaire assessments and smart scale body composition measurements at home at Baseline, Week 4, Week 8, and Week 12.
Participants replace a typical meal once daily with the study product for 12 consecutive weeks while continuing their existing GLP-1 or dual-incretin medication. The primary objective is to evaluate within-participant change in perceived nutritional adequacy from Baseline to Week 12. Secondary objectives include changes in body fat percentage, muscle mass, perceived skin health, hunger and satiety, hair health, energy and cognitive focus, nail health, gut comfort, metabolism support, physical strength, and product tolerability and satisfaction.
11,556 studies on the registry are indexed under Obesity; 2,055 are open to participants now.
This study's planned enrollment of 40 is below the median of 67 across 9,036 interventional studies indexed under Obesity.
Browse Obesity studies →The Collagen Co. - GLP-1 Users is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Dietary Supplement: Glow Shakes Premium Collagen Meal Replacement Intervention
Participants will consume one serving once daily - replacing a typical meal such as breakfast or lunch - for 12 consecutive weeks. One serving is prepared by adding the powder to 11.8 fl oz (approximately 350 mL) of water: add water first, then two scoops of powder, and shake for fewer than 10 seconds. Drink immediately after preparation.
Change in Perceived Nutritional Adequacy
Within-participant change in perceived nutritional adequacy assessed via self-report questionnaire
Time frame: Baseline to Week 12
Change in Body Fat Percentage
Within-participant change in body fat percentage (%) measured by participant self-administered Withings smart scale
Time frame: Baseline to Week 12
Change in Muscle Mass
Within-participant change in muscle mass (kg) measured by participant self-administered Withings smart scale
Time frame: Baseline to Week 12
Change in Self-Reported Weight Management and Food Cravings
Within-participant change assessed via the validated Food Cravings Questionnaire-Trait Reduced (FCQ-T-reduced)
Time frame: Baseline to Week 12
Change in Self-Reported Perceived Skin Smoothness
Within-participant change in perceived skin smoothness score assessed via self-report questionnaire
Time frame: Baseline to Week 12
Change in Self-Reported Perceived Skin Elasticity
Within-participant change in perceived skin elasticity score assessed via self-report questionnaire
Time frame: Baseline to Week 12
Change in Self-Reported Hunger Intensity
Within-participant change in perceived hunger intensity assessed via visual analogue scale or equivalent validated hunger/satiety instrument
Time frame: Baseline to Week 12
Change in Self-Reported Satiety Duration
Within-participant change in perceived satiety duration assessed via visual analogue scale or equivalent validated hunger/satiety instrument
Time frame: Baseline to Week 12
Change in Self-Reported Food Craving Scores
Within-participant change in food craving scores assessed via the Food Cravings Questionnaire-Trait Reduced (FCQ-T-reduced)
Time frame: Baseline to Week 12
Change in Self-Reported Hair Thickness
Within-participant change in perceived hair thickness assessed via self-report questionnaire
Time frame: Baseline to Week 12
Change in Self-Reported Hair Health
Within-participant change in perceived hair health assessed via self-report questionnaire
Time frame: Baseline to Week 12
Change in Self-Reported Energy Levels
Within-participant change in perceived energy levels assessed via self-report questionnaire
Time frame: Baseline to Week 12
Change in Self-Reported Cognitive Focus
Within-participant change in perceived cognitive focus assessed via self-report questionnaire
Time frame: Baseline to Week 12
Change in Self-Reported Nail Thickness
Within-participant change in perceived nail thickness assessed via self-report questionnaire
Time frame: Baseline to Week 12
Change in Self-Reported Nail Health
Within-participant change in perceived nail health assessed via self-report questionnaire
Time frame: Baseline to Week 12
Change in Gut Comfort and Digestive Health
Within-participant change in gut comfort and digestive symptom scores assessed via self-report questionnaire
Time frame: Baseline to Week 12
Change in Self-Reported Metabolism Support
Within-participant change in perceived metabolism support assessed via self-report questionnaire
Time frame: Baseline to Week 12
Change in Self-Reported Physical Strength
Within-participant change in perceived physical strength assessed via self-report questionnaire
Time frame: Baseline to Week 12
Product Tolerability and Participant Satisfaction
Participant-reported product satisfaction, acceptability, and tolerability assessed via product satisfaction questionnaire
Time frame: Week 12
Start is estimated for Nov 2026; primary completion for Jan 2027, 2 months later.
Of 164 industry-sponsored interventional studies with no phase under Obesity, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 27. This study's planned 2 months is below that.
Counting every sponsor, half of 3,858 studies reached it within 22 months; a quarter within 10 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The Collagen Co. - GLP-1 Users